SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001640334-19-000942
Filing Date
2019-05-20
Accepted
2019-05-20 20:37:12
Documents
1
Period of Report
2019-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 A form4a.html 4/A  
1 FORM 4 A form4a.xml 4/A 3850
  Complete submission text file 0001640334-19-000942.txt   5219
Mailing Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037
Business Address 1224 PROSPECT STREET SUITE 150 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 476 MASSACHUSETTS AVE, UNIT 2 BOSTON MA 02118
Business Address
Tesi Raymond Joseph (Reporting) CIK: 0001767280 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38793 | Film No.: 19840600